(Q37230165)

19 August 2017

Treatment outcome of cisplatin-based concurrent chemoradiotherapy in the patients with locally advanced nasopharyngeal cancer (English)

1 reference

19 August 2017

0 references

Tae Hee Kim

1

1 reference

19 August 2017

Yoon Ho Ko

2

1 reference

19 August 2017

Myung Ah Lee

3

1 reference

19 August 2017

Bum-soo Kim

4

1 reference

19 August 2017

So Ryoung Chung

5

1 reference

19 August 2017

Ie Ryung Yoo

6

1 reference

19 August 2017

Chan-Kwon Jung

7

1 reference

19 August 2017

Yeon-Sil Kim

8

1 reference

19 August 2017

Min Sik Kim

9

1 reference

19 August 2017

Dong-Il Sun

10

1 reference

19 August 2017

Young Seon Hong

11

1 reference

19 August 2017

Kyung Shik Lee

12

1 reference

19 August 2017

Jin-Hyoung Kang

13

1 reference

19 August 2017

language of work or name

1 reference

30 June 2008

1 reference

Cancer Research and Treatment

19 August 2017

1 reference

19 August 2017

40

1 reference

19 August 2017

2

1 reference

19 August 2017

62-70

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

19 August 2017

start time

30 June 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: randomised, non-inferiority, open trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697486

Nasopharyngeal carcinoma: molecular biomarker discovery and progress

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697486

Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697486

Advances in nasopharyngeal carcinoma

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697486

Tolerability of the Intergroup 0099 (INT 0099) regimen in locally advanced nasopharyngeal cancer with a focus on patients' nutritional status

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697486

Treatment of locally advanced head and neck cancer: historical and critical review

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697486

The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697486

Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697486

Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697486

Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varie

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697486

Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697486

Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697486

Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697486

Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697486

Causes of interruption of radiotherapy in nasopharyngeal carcinoma patients in Taiwan

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697486

The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697486

Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma: is Intergroup Study 0099 Feasible in Japanese Patients?

3 September 2018

1 reference

12 December 2020

Nasopharyngeal carcinoma

1 reference

12 December 2020

Prognostic significance of keratinization in nasopharyngeal carcinoma

1 reference

12 December 2020

Nasopharyngeal carcinoma

1 reference

12 December 2020

Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation

1 reference

12 December 2020

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

12 December 2020

Identifiers

DOI

10.4143/CRT.2008.40.2.62

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19688050

1 reference